High dose melphalan (HDM) is superior to cyclophosphamide plus etoposide and busulfan (CVB) as the conditioning regimen in autologous stem cell transplantation for multiple myeloma

被引：0

作者：

谷景立 ^{[1
]}

机构：

[1] Affil Hosp, Sun Yat-sen Univ

来源：

China Medical Abstracts(Internal Medicine) | 2019年 / 36卷 / 04期

关键词：

HDM; CVB; High dose melphalan; as the conditioning regimen in autologous stem cell transplantation for multiple myeloma; is superior to cyclophosphamide plus etoposide and busulfan;

D O I：

暂无

中图分类号：

R733.3 [骨髓肿瘤];

学科分类号：

100214 ;

摘要：

Objective To compare the efficacy,response and survival between high-dose melphalan(HDM) and cyclophosphamide+etoposide+busulfan(CVB) as the conditioning regimen in autologous stem cell transplantation(ASCT) for newly diagnosed multiple myeloma

引用

页码：230 / 231

页数：2